ZN-e4

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameZN-e4
Drug Alias NameZN-e4KP-673
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitorsEGFR T790M inhibitors
TargetsEpidermal growth factor receptor erbB1EGFR T790M
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBosnia and HerzegovinaUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesZeno PharmaZentalis Pharmaceuticals LLC
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZeno Pharmaceuticals IncSciclone Pharmaceutical Jiangsu Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A